Status:
RECRUITING
North West London Pebble Pathway: Automated OSA Diagnosis
Lead Sponsor:
Patrik Bachtiger
Conditions:
Obstructive Sleep Apnea
Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with obstructive sleep apnoea (OSA) wait up to two years for a diagnostic test. Early diagnosis enables optimal treatment, mitigating risks including heart failure, lung disease, and stroke. ...
Detailed Description
The investigators are conducting a prospective implementation and health economic study of a novel straight-to-test (STT) clinical diagnostic pathway for OSA, using a novel, regulatory-approved wearab...
Eligibility Criteria
Inclusion
- OSA testing referral from primary care
Exclusion
- Unable to follow test instructions
Key Trial Info
Start Date :
July 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06507228
Start Date
July 7 2024
End Date
December 1 2025
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charing Cross Hospital
London, United Kingdom, W12 0HS